Prof. Jing Wang 王晶
Chief Physician, Professor
Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of ovarian, cervical, endometrial, vulvar cancers, gestational trophoblastic tumors, cervical diseases, and uterine fibroids, with a focus on recurrent and refractory ovarian cancer.
Dr. Wang is Chief Physician and Professor at Harbin Medical University Cancer Hospital, leading the Third Gynecology Department. Holding a medical doctorate, Dr. Wang has worked in gynecologic oncology since 1988. Research includes over ten projects and forty publications. Dr. Wang introduced vulvar reconstruction using gracilis muscle flaps after radical vulvectomy in Heilongjiang Province.
Professional roles
- Chair, Gynecologic Oncology Youth Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Gynecologic Oncology Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Women's Health Professional Committee, Heilongjiang Preventive Medicine Association
- Editorial Board Member, Journal of Oncology
Name order: in Chinese the family name comes first (Wang Jing). Papers usually list the name as Jing Wang or Wang J.
Selected publications
46 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Discov Oncol, 2025 (first author): Identification of copper related biomarkers in breast cancer using machine learning. PubMed 40767901
- Int J Gen Med, 2024 (senior author): Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma. PubMed 38525069
- Immunotargets Ther, 2024 (senior author): The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study. PubMed 38352235
- Heliyon, 2023 (senior author): Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgery. PubMed 38027616
- Front Genet, 2022 (senior author): Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer. PubMed 36425071
- Hum Pathol, 2018 (first author): Tumor necrosis factor α-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy. PubMed 30107189
- Cancer Sci, 2018 (senior author): Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer. PubMed 29478268
- Sci Rep, 2017 (first author): Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer. PubMed 28646161
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion